FMR CORP 13D/13G Filings for Prime Medicine, Inc. (PRME)

FMR CORP 13D and 13G filings for Prime Medicine, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-12
10:34 am
Sale		 2024-11-08 13G Prime Medicine, Inc.
PRME		 FMR CORP 7,726,649
6.437%		 -1,361,501decrease
(-14.98%)		 Filing
2024-02-09
09:49 am
Purchase		 2024-02-08 13G Prime Medicine, Inc.
PRME		 FMR CORP 9,088,150
9.338%		 625,104increase
(+7.39%)		 Filing
2023-02-09
08:14 am
Purchase		 2023-02-09 13G Prime Medicine, Inc.
PRME		 FMR CORP 8,463,046
8.706%		 100increase
(+0.00%)		 Filing
2022-10-26
10:20 am
Purchase		 2022-10-26 13G Prime Medicine, Inc.
PRME		 FMR CORP 8,462,946
8.840%		 8,462,946increase
(New Position)		 Filing